This article is based on a poster originally authored by Daniel A. Barr, Mario Öeren, Peter A. Hunt, Jonathan D. Tyzack, Tomáš Chrien, Tamsin E. Mansley and Matthew D. Segall, which was presented at ...
Atom Therapeutics, a clinical stage biotechnology company developing best-in-class treatments for inflammatory and metabolic diseases, today announced FDA approval of a Phase II clinical trial ...
Vietnam Investment Review on MSN
Caliway submits CBL-514 for FDA phase 2 weight management trial
The drug candidate aims to reduce fat and is being developed for use alongside existing GLP-1 receptor agonist therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback